Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{CMG}} ==2011 AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease<ref name=Secondary-Prev...")
 
No edit summary
Line 7: Line 7:
===Physical activity===
===Physical activity===
Goal: At least 30 minutes, 7 days per week (minimum 5 days per week)
Goal: At least 30 minutes, 7 days per week (minimum 5 days per week)
===Weight management==
===Weight management===
Goals: Body mass index: 18.5 to 24.9 kg/m2 Waist circumference: women �35 inches (�89 cm), men 40 inches (�102 cm)
Goals: Body mass index: 18.5 to 24.9 kg/m2 Waist circumference: women <35 inches (<89 cm), men 40 inches (<102 cm)
===Type 2 diabetes mellitus management===
===Type 2 diabetes mellitus management===
===Antiplatelet agents/anticoagulants===
===Antiplatelet agents/anticoagulants===
===Antiplatelet agents/anticoagulants cont’d===
===Antiplatelet agents/anticoagulants cont’d===
===Renin-angiotensin-aldosterone system blockers===
===Renin-angiotensin-aldosterone system blockers===
===�Blockers===
===Blockers===
===�-Blockers cont’d===
===Blockers cont’d===
===Influenza vaccination===
===Influenza vaccination===
===Depression===
===Depression===
===Cardiac rehabilitation===
===Cardiac rehabilitation===

Revision as of 18:54, 28 October 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

2011 AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease[1]

Smoking

Blood pressure control

Lipid management

Physical activity

Goal: At least 30 minutes, 7 days per week (minimum 5 days per week)

Weight management

Goals: Body mass index: 18.5 to 24.9 kg/m2 Waist circumference: women <35 inches (<89 cm), men 40 inches (<102 cm)

Type 2 diabetes mellitus management

Antiplatelet agents/anticoagulants

Antiplatelet agents/anticoagulants cont’d

Renin-angiotensin-aldosterone system blockers

Blockers

Blockers cont’d

Influenza vaccination

Depression

Cardiac rehabilitation

  1. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update http://ac.els-cdn.com/S0735109711043567/1-s2.0-S0735109711043567-main.pdf?_tid=49947b56-9d3e-11e6-a5c0-00000aab0f6c&acdnat=1477680333_bca68af215739ff9481a8a528bdd9554 Accessed on October 28, 2016